Header cover image

Danish Biotech Stocks

Results

7

0 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

7 companies

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

NOVO B

DKK 456.60

7D

5.5%

1Y

-50.5%

Genmab

Market Cap: DKK 82.6b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,375.00

7D

6.1%

1Y

-33.1%

H. Lundbeck

Market Cap: DKK 34.3b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 36.96

7D

9.7%

1Y

-0.4%

Bavarian Nordic

Market Cap: DKK 13.3b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 172.70

7D

7.8%

1Y

-3.1%

Gubra

Market Cap: DKK 6.7b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

GUBRA

DKK 415.00

7D

6.2%

1Y

33.9%

Pharma Equity Group

Market Cap: DKK 98.2m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.

PEG

DKK 0.076

7D

-8.2%

1Y

-70.5%

Strategic Partners

Market Cap: DKK 45.0m

Does not have significant operations.

STRAP

DKK 1,040.00

7D

-0.5%

1Y

2.0%